These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11738)

  • 1. [Determination of rifamycin B activity in culture liquids and in preparations with varying degrees of purity].
    Makarova RA; Rezvan SP; Dzegilenko NB; Birlova LV; Chaĭkovskaia SM
    Antibiotiki; 1976 Aug; 21(8):685-8. PubMed ID: 11738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extraction of rifamycin B from native and aqueous solutions].
    Tolstykh IV; Konstantinova NV; Grishin IA; Pokras LS
    Antibiotiki; 1975 Mar; 20(3):222-5. PubMed ID: 237467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromatographic control of the process of rifamycin B isolation and purification].
    Dzegilenko NB; Korchagin VB; Birlova LV
    Antibiotiki; 1976 Feb; 21(2):115-8. PubMed ID: 5945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3.
    Mahalaxmi Y; Sathish T; Prakasham RS
    Lett Appl Microbiol; 2009 Nov; 49(5):533-8. PubMed ID: 19793193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increase in the sensitivity and a simplification of the method for the separate determination of antibiotic activities in combined preparations (oletetrin) by using media with a varying pH value].
    Makarova RA; Levkovich NM; Suvorkina DV; Chaĭkovskaia SM
    Antibiotiki; 1980 Sep; 25(9):680-3. PubMed ID: 6774662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of rifamycin complex].
    Oner M; Tamer AU; Bursalioğlu M
    Mikrobiyol Bul; 1987 Oct; 21(4):296-300. PubMed ID: 3503969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stability of rifamycin B in aqueous solutions].
    Birlova LV; Popova VB; Zhukovskaia SA
    Antibiotiki; 1983 Jul; 28(7):514-7. PubMed ID: 6625547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the biological activity of antibiotics by using dry nutrient media].
    Grigor'eva VM; Astanina LN; Klimova NE
    Antibiotiki; 1983 Mar; 28(3):195-8. PubMed ID: 6859820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.
    Bapat PM; Bhartiya S; Venkatesh KV; Wangikar PP
    Biotechnol Bioeng; 2006 Mar; 93(4):779-90. PubMed ID: 16302259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rifamycin in B distribution between aqueous and organic phases].
    Birlova IV; Zhukovskaia SA; Medvedeva VI; Popova VB
    Antibiotiki; 1978 Apr; 23(4):304-7. PubMed ID: 25614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standardization of the nutrient medium for determining the biological activity of a number of antibiotics by the diffusion-in-agar method].
    Bershteĕin EM; Vasil'eva NG; Poliak MS
    Antibiotiki; 1983 Apr; 28(4):250-4. PubMed ID: 6407390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex].
    Yamamoto T; Amitani R; Kuze F; Suzuki K
    Kekkaku; 1990 Dec; 65(12):805-10. PubMed ID: 2127615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential spectrophotometric method of analysing levorin in the culture broth and in the mycelium].
    Bob TG; Barabanshchikova GV; Raĭgorodskaia VIa; Etingov ED; Fradkova TA
    Antibiotiki; 1978 Oct; 23(10):882-5. PubMed ID: 81654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.
    Jin ZH; Lin JP; Cen PL
    J Zhejiang Univ Sci; 2004 Dec; 5(12):1590-6. PubMed ID: 15547969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.
    Bapat PM; Wangikar PP
    Biotechnol Bioeng; 2004 Apr; 86(2):201-8. PubMed ID: 15052640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media.
    Bapat PM; Sohoni SV; Moses TA; Wangikar PP
    Appl Microbiol Biotechnol; 2006 Oct; 72(4):662-70. PubMed ID: 16534611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.
    Bapat PM; Das D; Dave NN; Wangikar PP
    J Biotechnol; 2006 Dec; 127(1):115-28. PubMed ID: 16904217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the nutrient medium components on the formation of growth inhibition zones of the test microbe in determining the biological activity of mycoheptin].
    Vasil'eva NG; Fradkova TA
    Antibiotiki; 1979 Mar; 24(3):185-9. PubMed ID: 36026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New rifamycins. II. Synthesis and biological activity of oximes, hydrazones, and semicarbazones of 3-N-(piperidin-4-one)rifamycin S.
    Marsili L; Franceschi G; Galliani C; Sanfilippo A; Vigevani A
    Farmaco Sci; 1982 Dec; 37(12):781-6. PubMed ID: 7152013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Optimization of conditions for determining the activity of amphotericin B].
    Bershteĭn EM
    Antibiotiki; 1977 Jan; 22(1):13-6. PubMed ID: 14589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.